Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein
more »
- The Hospital for Sick Children Research Inst., Toronto, ON (Canada); Univ. of Toronto, ON (Canada)
- German Cancer Research Center (DKFZ), Heidelberg (Germany)
- Kymab Ltd./Sanofi, Cambridge (United Kingdom); RQ Biotechnology Ltd., London (United Kingdom)
- The Hospital for Sick Children Research Inst., Toronto, ON (Canada)
- German Cancer Research Center (DKFZ), Heidelberg (Germany); Heidelberg Univ. (Germany)
- Johns Hopkins Univ., Baltimore, MD (United States)
- Duke Univ., Durham, NC (United States)
- TropIQ Health Sciences, Nijmegen (Netherlands)
- Kymab Ltd./Sanofi, Cambridge (United Kingdom); RQ Biotechnology Ltd., London (United Kingdom); Imperial College, London (United Kingdom)
IGHV3-33-encoded antibodies are prevalent in the human humoral response against the Plasmodium falciparum circumsporozoite protein (PfCSP). Among VH3-33 antibodies, cross-reactivity between PfCSP major repeat (NANP), minor (NVDP), and junctional (NPDP) motifs is associated with high affinity and potent parasite inhibition. However, the molecular basis of antibody cross-reactivity and the relationship with efficacy remain unresolved. Here, we perform an extensive structure-function characterization of 12 VH3-33 anti-PfCSP monoclonal antibodies (mAbs) with varying degrees of cross-reactivity induced by immunization of mice expressing a human immunoglobulin gene repertoire. We identify residues in the antibody paratope that mediate cross-reactive binding and delineate four distinct epitope conformations induced by antibody binding, with one consistently associated with high protective efficacy and another that confers comparably potent inhibition of parasite liver invasion. Our data show a link between molecular features of cross-reactive VH3-33 mAb binding to PfCSP and mAb potency, relevant for the development of antibody-based interventions against malaria.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS); Brookhaven National Laboratory (BNL), Upton, NY (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities (SUF)
- Grant/Contract Number:
- AC02-06CH11357; SC0012704
- OSTI ID:
- 2470070
- Journal Information:
- Cell Reports, Journal Name: Cell Reports Journal Issue: 11 Vol. 42; ISSN 2211-1247
- Publisher:
- ElsevierCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
High-density binding to Plasmodium falciparum circumsporozoite protein repeats by inhibitory antibody elicited in mouse with human immunoglobulin repertoire
Molecular and functional properties of human Plasmodium falciparum CSP C-terminus antibodies
Structural ordering of the Plasmodium berghei circumsporozoite protein repeats by inhibitory antibody 3D11
Journal Article
·
Sun Nov 27 19:00:00 EST 2022
· PLoS Pathogens
·
OSTI ID:2470050
Molecular and functional properties of human Plasmodium falciparum CSP C-terminus antibodies
Journal Article
·
Thu Apr 20 20:00:00 EDT 2023
· EMBO Molecular Medicine
·
OSTI ID:2423519
Structural ordering of the Plasmodium berghei circumsporozoite protein repeats by inhibitory antibody 3D11
Journal Article
·
Sun Nov 29 19:00:00 EST 2020
· eLife
·
OSTI ID:1736286